Bausch

Business

Bausch Health gains amid win in Norwich case over generic Xifaxan (NYSE:BHC)

JHVEPhoto/iStock Editorial via Getty Images Update 11:45am: Adds analyst comment. Bausch Health (NYSE:BHC) rose 4% amid a win in a…

Read More »
Back to top button